Filling the void: a role for exercise-induced BDNF and brain amyloid precursor protein processing

Area of Science:

• Neuroscience
• Metabolic disease
• Aging

Background:

• Obesity, inactivity, and insulin resistance are key Alzheimer's disease (AD) risk factors.
• These conditions worsen AD neuropathology, including beta-amyloid peptide aggregation.
• Beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) drives beta-amyloid formation, making its regulation crucial for AD therapies.

Purpose of the Study:

• To review the direct impact of exercise on beta-amyloid production in the brain.
• To explore the role of brain-derived neurotrophic factor (BDNF) in mediating exercise's effects on BACE1 and beta-amyloid.

Main Methods:

• Literature review focusing on exercise, obesity, insulin resistance, and Alzheimer's disease.
• Analysis of studies investigating the direct effects of exercise on amyloid precursor protein (APP) processing.
• Examination of the proposed mechanisms involving BDNF.

Main Results:

• Exercise training reduces AD risk and beta-amyloid production, but confounding metabolic improvements complicate direct effect assessment.
• Existing research suggests exercise can decrease BACE1 activity and content.
• BDNF is hypothesized to be a key mediator, directly linking exercise to reduced BACE1 and beta-amyloid.

Conclusions:

• A significant knowledge gap exists regarding exercise's direct effects on brain APP processing.
• BDNF may play a central role in mediating exercise-induced reductions in BACE1 and beta-amyloid.
• Further research is needed to understand how obesity and exercise directly influence APP processing for potential AD therapies.